期刊文献+

疑似脊髓性肌萎缩症患儿338例的运动神经元存活基因分析 被引量:21

Molecular analysis of survival motor neuron gene in 338 suspicious children patients with spinal muscular atrophy
原文传递
导出
摘要 目的研究儿童脊髓性肌萎缩症(SMA)运动神经元存活基因SMN1缺失和诊断的意义。方法根据国际诊断标准、病例随访和基因分析结果对338例疑似SMA的患儿进行诊断和分型。应用PCR-酶切方法分析患儿SMN1基因外显子7和外显子8的纯合缺失。应用等位基因特异PCR结合变性高效液相色谱分析(DHPLC)方法分析患儿的SMN1基因拷贝数,确定杂合缺失。结果(1)确诊SMA267例,其中Ⅰ型143例,Ⅱ型82例,Ⅲ型42例,分别占53.6%、30.7%和15.7%。(2)267例SMA患儿的SMN1基因缺失分析显示:SMN1基因外显子7和8均纯合缺失为183例,占68.5%(183/267),仅外显子7纯合缺失,外显子8不缺失为34例,占12.7%(34/267),外显子7杂合缺失为33例,占12.4%(33/267),非缺失为17例,占6.4%(17/267),未见SMN1基因外显子8的单独缺失。(3)Ⅰ型和Ⅱ型SMN1基因缺失率相近。Ⅲ型SMN1基因纯合缺失率较低于Ⅰ型和Ⅱ型,杂合缺失率较高于Ⅰ型和Ⅱ型。结论(1)我国儿童SMA的SMN1基因纯合缺失和杂合缺失频率提示,SMN1基因突变存在种族异质性,SMN1基因内微小突变需要研究。(2)SMN1基因诊断具有特异性和无创性,80%SMA患儿通过SMN1基因纯合缺失分析得到诊断。(3)Ⅲ型SMA的临床诊断和基因分析需要进一步研究。 Objective Spinal muscular atrophy (SMA) is an autosomal recessive disorder that results in symmetrical muscle weakness and wasting due to degeneration of the anterior horns of the spinal cord. The clinical picture of SMA is variable and childhood SMA has been classified into 3 types on the basis of the age of onset and clinical course. The survival motor neuron (SMN) gene was mapped to chromosome 5q13. The SMN1 gene has been recognized to be responsible for SMA because of homozygouse deletions or intragenic mutations in SMN1 results in childhood onset of SMA. The main objective of this study was to determine the deletion frequency of SMN1 gene and to apply gene analysis in children patients with SMA. Methods The SMA patients were diagnosed and clinically typed according to the international diagnostic criteria, following up cases, and gene analysis. The PCR enzyme assay was used to detect the homozygous deletion of SMN1 gene in SMA patients. A dosage assay that combined multiplexed allele-specific PCR and DHPLC was used to determine the copy numbers of the SMN1 and SMN2 and detect SMN1 heterozygous deletion. Results ( 1 ) A total of 267 patients with SMA were diagnosed from 338 suspicious cases and 143, 82, and 42 cases were typed as types Ⅰ ,Ⅱ, and Ⅲ with the percentages of 53.6% ( 143/267), 30.7% (82/267) and 15.7% (42/267), respectively. (2) Results of the present study showed that 68.5% ( 183/267 ) of SMA patients had homozygous deletions of exons 7 and 8 of SMN1 gene and 12.7% (34/267) had homozygous deletions of only exon 7 of SMN1 gene. The SMN1 heterozygous deletion was confirmed in 12.4% (33/267) of SMA patients. Non-deletion SMA patients accounted for 6.4% (17/267).The homozygous deletions of only exon 8 of SMN1 gene could not be detected. (3) The rates of homozygous or heterozygous deletion in types Ⅰand Ⅱwere very similar. The rate of homozygous deletion was lower in type Ⅲ than that in type Ⅰ or Ⅱ and rate of heterozygous deletion of type Ⅲ was higher than that in types Ⅰ or Ⅱ. Condusion ( 1 ) The frequency and pattern of deletions in the Chinese children patients with SMA are significantly different from that observed in Caucasians populations. Further gene characterization and subtle mutations within the SMN1 gene need to be studied in order to define the molecular basis of SMA in the Chinese population. (2) The gene diagnosis is a special and non invasive method as compared with other methods. A total of 80% patients can be diagnosed through the analysis of the homozygous deletion of SMN1 gene. (3) The clinical diagnosis and gene detection need to be studied in future for the SMA patients with type Ⅲ.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2008年第12期919-923,共5页 Chinese Journal of Pediatrics
基金 基金项目:“十五”国家科技攻关计划项目(2004BA720A04)部分资助 志谢所有提供病例的医生和提供标本的患儿及家庭对本研究的支持 中国医学科学院基础医学研究所黄尚志教授对SMN基因拷贝数分析给予的帮助
关键词 脊髓性肌萎缩 儿童 基因 Spinal muscular atrophy of childhood Gene
  • 相关文献

参考文献17

  • 1Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurology, 2007, 22:946-951.
  • 2Lefbvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy determing gene. Cell, 1995,80 : 155-165.
  • 3Munsat TM, davies KE. Meeting report: international SMA consortium meeting. Neuromuscul Disord, 1992,2 ( 5/6 ) : 423- 428.
  • 4龙美娟,宋昉,瞿宇晋,孟岩,王红,金煜炜,黄尚志.运用DHPLC技术分析非纯合缺失型脊髓性肌萎缩症患儿的SMN基因拷贝数[J].中华医学杂志,2008,88(18):1259-1263. 被引量:6
  • 5Thieme A, Mitulla B, Schulze F, et al. Epidemiological data on Werdning- Hoffmann disease in Germany (West-Thttringen). Hum Genet, 1993, 91: 295-297.
  • 6Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat, 2000, 15:228-237.
  • 7Kesari A, Misra UK, Kalita J, et al. Study of suevival of motor neuron(SMN) and neuronal apoptosis inhibitory protein (NAIP) gene deletions in SMA patients. J Neurol, 2005, 252:667-671.
  • 8al-Rajeh S, Majumdar R, Awada A, et al. Application of DNA-dased tests for diagnosis of spinal muscular atrophy in Saudi Arabia. East Medterr Health J ,1999, 5 : 1225-1229.
  • 9Labrum R, Rodda J, Krause A. The molecular basis of spinal muscular atrophy (SMA) in South African black patients. Neuromuscul Disord, 2007,17:684-692.
  • 10Campbell L, Potter A, Ignatius J, et al. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet, 1997, 61:40-50.

二级参考文献27

  • 1姚娟,丁新生,沈鸣九,吴芳玲,陈克连,王颖,陈伟贤,李弘钧,侯熙德.聚合酶链反应用于进行性脊髓性肌萎缩的诊断[J].中华检验医学杂志,1998,22(3):4-6. 被引量:2
  • 2卢丽萍,麻宏伟,姜俊,王涛,胡斌.脊髓性肌萎缩临床表型与SMN2基因拷贝数变化的相关性研究[J].中华医学遗传学杂志,2007,24(2):144-147. 被引量:11
  • 3Prior TW. Spinal muscular atrophy diagnostics. J Child Neurol, 2007, 22 : 952-956.
  • 4Leibvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy determing gene. Cell, 1995, 80: 155-165.
  • 5Hung CH, Chang YY, Chen CH, et al. Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification. Genet Med, 2007, 9: 241-248.
  • 6Lee TM, Kim SW, Lee KS, et al. Quantitative analysis of SMN1 gene and estimation of SMN1 deletion carrier frequency in Korean population base on real-time PCR. J Korean Med Sci, 2004, 19: 870-873.
  • 7Su YN, Hung CC, Li H, et al. Quantitative analysis of SMN1 and SMN2 gene based on DHPLC: a highly efficient and reliable carrier-screening test. Hum Mut, 2005, 25 : 460-467.
  • 8Sun Y, Grimmler M, Schwarzer V, et al. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy. Hum Murat. 2005. 25: 64-71.
  • 9Campbell L, Potter A, Ignatius J, et al. Genomic variation and gene conversion in spinal atrophy: implication for disease process and clinical phenotype. Am J Hum Genet, 1997, 61 : 40-50.
  • 10Mailman MD, Glasure CE, Heinz JW, et al. Hybrids monosomal for human chromosome 5 reveal the presence of a spinal muscular atrophy (SMA) carrier with two SMN1 copies on one chromosome. Hum Genet, 2001, 108 : 109-115.

共引文献34

同被引文献185

引证文献21

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部